Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated

Latest Threshold Suspend System Articles

Threshold Suspend System Archives
Print | Email | Share | Comments (0)

FDA Approves Medtronic’s Artificial Pancreas


Sep 30, 2013

The FDA has approved a new, automated artificial pancreas system from Minneapolis-based Medtronic, Inc.

The innovative, first-generation system is the first of its kind in the United States, and has the capability to automatically stop insulin delivery when blood glucose levels are either too high or too low.

The MiniMed 530G with Enlite sensor is one of many innovations in diabetic treatment options from Medtronic. The company developed the world's first insulin pump in 1983 and followed with an integrated insulin pump and glucose monitoring system in 2006.

In addition to an insulin pump and a continuous glucose monitor fitted with the improved Enlite sensor, the MiniMed 530G artificial pancreas includes the Threshold Suspend system, which has the capability to automatically stop insulin delivery in response to preset glucose levels determined by a healthcare provider.

Working in conjunction with the pump and monitor, the Threshold Suspend system uses advanced technology to automatically cease delivery of insulin if glucose levels reach a preset threshold and if the user is unable to respond to the Threshold Suspend alarm. If the user is sleeping, the system will suspend insulin delivery for up to two hours, reducing the risk of hypoglycemia or hyperglycemia.

For those with type 1 diabetes, where the pancreas no longer produces insulin, an artificial pancreas is designed to mimic the insulin delivery of a healthy pancreas by providing both continuous glucose monitoring and automatically adjusted insulin delivery that intervenes when glucose is severely low or severely high.

The MiniMed 530G system is approved for use by those with diabetes 16 and older, though Medtronic plans to conduct a post-approval study that will include children 2 and up.

For more information, visit www.medtronicdiabetes.com.


Categories: Artificial Pancreas, Enlite Sensor, Insulin Delivery, Medtronic, MiniMed 530G, Threshold Suspend System, Type 1



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Sep 30, 2013

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.